A multiplex preclinical model for adenoid cystic carcinoma of the salivary gland identifies regorafenib as a potential therapeutic drug. [electronic resource]
Producer: 20190621Description: 11410 p. digitalISSN:- 2045-2322
- Animals
- Antineoplastic Agents -- pharmacology
- Biomarkers, Tumor
- Carcinoma, Adenoid Cystic -- drug therapy
- Cell Line, Tumor
- Cell Transformation, Neoplastic -- genetics
- Disease Models, Animal
- Drug Evaluation, Preclinical
- Gene Expression Profiling
- Gene Expression Regulation, Neoplastic
- Humans
- In Situ Hybridization, Fluorescence
- Mice
- Microsatellite Repeats
- Oncogene Proteins, Fusion -- genetics
- Phenylurea Compounds -- pharmacology
- Pyridines -- pharmacology
- Salivary Gland Neoplasms -- drug therapy
- Xenograft Model Antitumor Assays
- Zebrafish
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.